These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4597735)

  • 1. Uptake of minocycline and tetracycline by tetracycline-susceptible and -resistant bacteria.
    Kuck NA; Forbes M
    Antimicrob Agents Chemother; 1973 Jun; 3(6):662-4. PubMed ID: 4597735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains.
    McMurry LM; Cullinane JC; Levy SB
    Antimicrob Agents Chemother; 1982 Nov; 22(5):791-9. PubMed ID: 6758689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
    Testa RT; Petersen PJ; Jacobus NV; Sum PE; Lee VJ; Tally FP
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2270-7. PubMed ID: 8285606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tetracycline and minocyclie transport in Escherichia Coli.
    Del Bene VE; Rogers M
    Antimicrob Agents Chemother; 1975 Jun; 7(6):801-6. PubMed ID: 1098571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci.
    Minuth JN; Holmes TM; Musher DM
    Antimicrob Agents Chemother; 1974 Oct; 6(4):411-4. PubMed ID: 4157335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
    Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT
    Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteriological and clinical study of a new tetracycline, minocycline].
    Veyssier P; Boussougant Y; Mariel C
    Pathol Biol (Paris); 1973 Jan; 21(1):59-67. PubMed ID: 4570516
    [No Abstract]   [Full Text] [Related]  

  • 8. Action of 12 tetracyclines on susceptible and resistant strains of Staphylococcus aureus.
    Sompolinsky D; Krausz J
    Antimicrob Agents Chemother; 1973 Sep; 4(3):237-47. PubMed ID: 4758832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of tetracycline resistance in Staphylococcus aureus.
    Asheshov EH
    J Gen Microbiol; 1975 May; 88(1):132-40. PubMed ID: 1151329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci.
    Goldstein FW; Kitzis MD; Acar JF
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2218-20. PubMed ID: 7811053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of magnesium and manganese on some biological and physical properties of tetracycline.
    Sompolinsky D; Samra Z
    J Bacteriol; 1972 May; 110(2):468-76. PubMed ID: 4553832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli.
    Chopra I; Shales S; Ball P
    J Gen Microbiol; 1982 Apr; 128(4):689-92. PubMed ID: 6750037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of two glycylcyclines against gram-positive bacteria.
    Eliopoulos GM; Wennersten CB; Cole G; Moellering RC
    Antimicrob Agents Chemother; 1994 Mar; 38(3):534-41. PubMed ID: 8203851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in susceptibility of Enterobacteriaceae and penicillin-resistant Staphylococcus aureus to tetracycline and minocycline.
    Candanoza C; Ellner PD
    Antimicrob Agents Chemother; 1975 Mar; 7(3):227-8. PubMed ID: 1040464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity in vitro and pharmacokinetics of minocycline (author's transl)].
    Simon C; Malerczyk V; Preuss I; Schmidt K; Grahmann H
    Arzneimittelforschung; 1976 Apr; 26(4):556-60. PubMed ID: 782466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptible Escherichia coli cells can actively excrete tetracyclines.
    McMurry LM; Aronson DA; Levy SB
    Antimicrob Agents Chemother; 1983 Oct; 24(4):544-51. PubMed ID: 6418064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli.
    Shales SW; Chopra I; Ball PR
    J Gen Microbiol; 1980 Nov; 121(1):221-9. PubMed ID: 7019387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteriological studies on minocycline, a new tetracycline derivative].
    Nakazawa S; Ono H; Nishino T; Kawabe H; Nishida K
    Jpn J Antibiot; 1969 Dec; 22(6):411-6. PubMed ID: 4986124
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America.
    Gales AC; Jones RN; Andrade SS; Pereira AS; Sader HS
    Braz J Infect Dis; 2005 Oct; 9(5):348-56. PubMed ID: 16410885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline resistance in Staphylococcus aureus: effect on phage susceptibility.
    Schaefler S; Francois W; Ruby CL
    Antimicrob Agents Chemother; 1976 Apr; 9(4):600-13. PubMed ID: 1267437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.